MAPT and Alzheimer disease: Our findings revealed that the presence of neuropathologically defined lesions characteristic of AGD-tau pathology is associated with lower levels of Aβ40 and p-tau181 in mixed AD cases, with the association between APOE4 and the AD-related molecules levels being less pronounced in the presence of AGD-tau.